Sitemap

• Patient Support
  • Patient Support Articles
  • Innovating for Patient
  • Resources and Tools
    • Instructions for the Reconstitution and Preparation for Injection of Verorab (Inactivated Rabies Vaccine)
• Products
  • Adacel
  • Epilim
  • Hexaxim
  • Praluent
  • Dupixent
    • Atopic Dermatitis/Prurigo Nodularis
      • Start with DUPIXENT and stay with confidence
      • Dosing and administration options
      • DUPIXENT has demonstrated long-term Safety and Tolerability
      • Disease Burden and Pathophysiology of AD & PN
      • It’s No Wonder, Patients see visible results
• Privacy Policy
• Terms & Conditions of Use
• Cookie Policy
• My Account
  • Manage My Account
  • Manage Preferences
  • Manage Subscriptions
  • Manage Password
  • Unsubscribe
• Login
• Sitemap
• Campus MY Sanofi Terms of Use
• Campus MY Sanofi PDPN
• Search
• Science
  • Cutting Edge Science
    • Cardiovascular
      • Hypertension
        • 2022
        • 2023
        • 2024
          • Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in patients with hypertension
          • Self-reported single adherence question scored on a visual analogue scale predicts cardiovascular outcomes and mortality
        • 2025
          • Management of Hypertension in Diabetic Nephropathy Patients - Dr. SP Chan
          • Pharmacological Management of Hypertension: The ESC 2024 Guideline Updates
      • Acute Coronary Syndrome
        • 2022
        • 2023
        • 2024
        • 2025
          • Antiplatelet Therapy in ACS: Moving Beyond One-Size-Fits-All
          • Evidence-Based Antiplatelet Selection in ACS patients
          • P2Y12 inhibitors vs. NSAIDs : Latest Evidence for Optimal Antiplatelet Therapy
    • Immunology
      • Atopic Dermatitis/Prurigo Nodularis
        • 2022
        • 2025
          • What's New in Pediatric Atopic Dermatitis?
          • Impact & Treatment of Atopic Dermatitis in Children
          • Common FAQs about Atopic Dermatitis
          • An Overview of Cumulative Life Course Impairment (CLCI)
        • 2026
          • DUPIXENT delivers a high standard of efficacy in children
          • DUPIXENT delivers a high standard of efficacy in adults
          • LIBERTY AD SOLO-CONTINUE (18+ years)
          • LIBERTY AD HAFT (12+)
          • LIBERTY AD CHRONOS (18+ years)
          • Infant and young child data
          • Attenuating the atopic march: Meta Analysis of The Dupilumab Atopic Dermatitis Database for Incident Allergic Events
      • Asthma
        • 2025
          • A Comparison of the Effectiveness of Biologic Therapies for Asthma: A Systematic Review and Network Meta-Analysis
          • Real-Life Indirect Case Matched Comparison of Dupilumab and Tezepelumab on Airway Oscillometry
        • 2025
          • Understanding Mucus Burden in Asthma
          • Type 2 Asthma Remission: Latest Data
      • CRSwNP
        • 2025
          • Updated Evidence from the EVEREST Phase 4 Trial
          • Dupilumab Real-World Effectiveness in CRSwNP: AROMA Registry Results
          • ASEAN Delphi Consensus on CRSwNP: Infographic Summary
    • Neurology
      • 2023
      • 2025
        • Meet Julius, a patient with recent Transient Ischemic Attack (TIA): How can Plavix® help?
    • Rare Disease
      • DBS
        • 2024
      • Gaucher
        • 2022
        • To Be a Detective: Finding Gaucher Patients
          Hint 1: All-In-One Tool for Easier Gaucher Patient Identification
        • To Be a Detective: Finding Gaucher Patients
          Hint 2: How to Differentiate Gaucher Disease Type 1 VS Type 3 And the Likelihood of Symptoms Occurring
      • Pompe
        • 2022
        • 2025
          • With Pompe Disease : Time is muscle LOPD Treatment Guide for appropriate and timely intervention
    • Vaccines
      • General
        • 2023
        • 2024
          • World Immunisation Week 2024
      • RSV
        • 2025
          • The power to reduce the chaos of RSV season
        • 2026
          • Beyfortus®: Insights from real-world studies (NIRSE-GAL & NirseCL)
          • Expert consensus on the burden of RSV disease and the utility of nirsevimab for disease prevention and
            protection of infants
  • Events
    • Upcoming Events
    • Past Events
      • Cardiovascular
        • Hypertension
        • ACS
      • Immunology
      • Rare Disease
        • Pompe
        • Gaucher
        • United in RARE: Advancing LSDs Care Across ASIA
        • United in RARE: Advancing LSDs Care Across ASIA
      • Vaccines
        • Influenza
        • Pregnancy
        • RSV
        • Key insights from WSPID 2025 are here!
• Registration